Avricore Health Valuation

AVCRF Stock  USD 0.05  0.02  24.02%   
Avricore Health seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Avricore Health from analyzing the firm fundamentals such as Current Valuation of 21.9 M, return on equity of -0.38, and Profit Margin of (0.95) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
0.05
Please note that Avricore Health's price fluctuation is out of control at this time. Calculation of the real value of Avricore Health is based on 3 months time horizon. Increasing Avricore Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Avricore pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Avricore Health. Since Avricore Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Avricore Pink Sheet. However, Avricore Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.0503 Real  0.0386 Hype  0.05 Naive  0.069
The real value of Avricore Pink Sheet, also known as its intrinsic value, is the underlying worth of Avricore Health Company, which is reflected in its stock price. It is based on Avricore Health's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Avricore Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
0.04
Real Value
29.30
Upside
Estimating the potential upside or downside of Avricore Health helps investors to forecast how Avricore pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Avricore Health more accurately as focusing exclusively on Avricore Health's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.020.050.07
Details
Hype
Prediction
LowEstimatedHigh
0.000.0529.31
Details
Naive
Forecast
LowNext ValueHigh
00.0729.33
Details

Avricore Health Total Value Analysis

Avricore Health is presently projected to have takeover price of 21.9 M with market capitalization of 25.64 M, debt of 40 K, and cash on hands of 1.44 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Avricore Health fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
21.9 M
25.64 M
40 K
1.44 M

Avricore Health Investor Information

The company recorded a loss per share of 0.01. Avricore Health last dividend was issued on the 21st of November 2016. The entity had 1:4 split on the 21st of November 2016. Avricore Health is not in a good financial situation at this time. It has a very high probability of going through financial hardship in August.

Avricore Health Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Avricore Health has an asset utilization ratio of 5.38 percent. This implies that the Company is making $0.0538 for each dollar of assets. An increasing asset utilization means that Avricore Health is more efficient with each dollar of assets it utilizes for everyday operations.

Avricore Health Ownership Allocation

Avricore Health holds a total of 98.62 Million outstanding shares. Avricore Health shows 8.58 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Avricore Health Profitability Analysis

The company reported the revenue of 122.81 K. Net Loss for the year was (1.71 M) with profit before overhead, payroll, taxes, and interest of 30.52 K.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Avricore Health's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Avricore Health and how it compares across the competition.

About Avricore Health Valuation

The pink sheet valuation mechanism determines Avricore Health's current worth on a weekly basis. Our valuation model uses a comparative analysis of Avricore Health. We calculate exposure to Avricore Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Avricore Health's related companies.
Avricore Health Inc. engages in the health data and point-of-care technologies business in Canada. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada. Avricore Health is traded on OTC Exchange in the United States.

8 Steps to conduct Avricore Health's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Avricore Health's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Avricore Health's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Avricore Health's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Avricore Health's revenue streams: Identify Avricore Health's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Avricore Health's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Avricore Health's growth potential: Evaluate Avricore Health's management, business model, and growth potential.
  • Determine Avricore Health's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Avricore Health's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Avricore Health Growth Indicators

Investing in growth stocks can be very risky. If the company such as Avricore Health does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding92.6 M
Retained Earnings-30.2 M

Complementary Tools for Avricore Pink Sheet analysis

When running Avricore Health's price analysis, check to measure Avricore Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avricore Health is operating at the current time. Most of Avricore Health's value examination focuses on studying past and present price action to predict the probability of Avricore Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avricore Health's price. Additionally, you may evaluate how the addition of Avricore Health to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
CEOs Directory
Screen CEOs from public companies around the world
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities